Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3796636 | 1.00 | ALDH1A1 (0.34) | ALDH1A1CYP3A4CYP2D6MAPTCYP2C19 | |
| SCHEMBL8435347 | 0.84 | ALDH1A1 (0.32) | ALDH1A1CYP3A4CYP2D6MAPTCYP2C19 | |
| SCHEMBL290896 | 0.84 | TBXAS1 (0.35) | — | |
| SCHEMBL111604 | 0.84 | TBXAS1 (0.35) | — | |
| SCHEMBL2121970 | 0.83 | ALDH1A1 (0.31) | ALDH1A1CYP3A4CYP2D6MAPTCYP2C19 | |
| SCHEMBL2175550 | 0.83 | — | — | |
| Hydrogen Sulfide SCHEMBL379592 | 0.82 | TBXAS1 (0.34) | — | |
| SCHEMBL1425197 | 0.82 | TBXAS1 (0.34) | — | |
| SCHEMBL1425200 | 0.82 | TBXAS1 (0.34) | — | |
| SCHEMBL28580526 | 0.81 | LMNA (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3567083-A1 | INSULATING AND HEAT-RADIATING COATING COMPOSITION, AND INSULATING AND HEAT-RADIATING PRODUCT IMPLEMENTED THEREWITH | Amosense Co.,Ltd (KR) | 2019-11-13 | — | — | EP | disclosed |
| US-9974716-B2 | Dental primer formulation | IVOCLAR VIVADENT AG (LI) | 2018-05-22 | — | — | US | disclosed |
| US-20160022549-A1 | DENTAL PRIMER FORMULATION | IVOCLAR VIVADENT AG (LI) | 2016-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160022549-A1 | DENTAL PRIMER FORMULATION | F12, H1-2, H1-0 | ALDH1A1 2432/4885CYP3A4 3256/4885CYP2D6 3110/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.